Thank you for Subscribing to CIO Applications Weekly Brief

Microbiology & Sterilization for Pharmaceuticals
Employing a Robust Sterilization Process to Eliminate Cross-Contamination and Maintain Product Sterility.
By
CIO Applications | Friday, November 30, 2018

Philadelphia, PA: By attending this marcus evans, Microbiology & Sterilization for Pharmaceuticals conference, professionals in sterilization, sterility assurance, microbiology and quality will be brought together to discuss strategic ways to improve their pharmaceutical sterilization process and optimize their product output.
Sterilization is a critical component of the preparation of a pharmaceutical product. There is greater importance to have a robust sterilization process in place, so then vulnerabilities for potential cross-contamination are eliminated. It’s key to identify which sterilization methods are best to use on certain products. The microbiology market has significantly grown in recent years. With this expansion and increased demand come hurdles for the industry. This event will address different principles of sterilization and microbiology and ways in which it destroys pathogens and prevents transmission to aseptic processing, sterility assurance and terminal sterilization, as well as best practices in cleaning & disinfection and contamination control.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
CIO Review Client: Flagship
More in News

